WBC
PRLB icon

West Branch Capital’s Protolabs PRLB Stock Holding History

West Branch Capital’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29
Closed -$2K – 469
2021
Q3 		$2K Hold
29
– – ﹤0.01% 392
2021
Q2 		$3K Buy
+29
New +$2.86K ﹤0.01% 399

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

West Branch Capital's PRLB Position: Q4 2021 in Review

West Branch Capital sold out of Protolabs (PRLB) in Q4 2021, closing a stake of 29 shares — an estimated $2K sold.

West Branch Capital first reported a position in PRLB in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 245 funds tracked by Wall St. Rank hold PRLB as of Q4 2021.

  • West Branch Capital reported no remaining Protolabs position as of Q4 2021 after selling out during the quarter.
  • West Branch Capital sold 29 Protolabs shares in Q4 2021, an estimated $2K.
  • West Branch Capital first reported a position in Protolabs in Q2 2021 and held it in 2 quarters.
  • West Branch Capital's Protolabs position peaked at $3K in Q2 2021.
  • 245 funds tracked by Wall St. Rank held Protolabs as of Q4 2021.

Based on West Branch Capital's 13F filing for Q4 2021, filed 24 Jan 2022.